The vaccine being used in the nationwide HPV vaccine rollout is Gardasil4 India’s health system was fully prepared to monitor ...

Deputy Commissioner Gulpreet Singh Aulakh today directed officials to ensure the effective implementation of the Human ...

Health and Family Welfare Minister Dr Balbir Singh on Friday launched a state-level Human Papilloma Virus (HPV) vaccination ...

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...

The American Medical Association and a leading public health research group focused on vaccines are teaming up to create a system to review vaccine safety and effectiveness, mirroring a role long ...

Please provide your email address to receive an email when new articles are posted on . HHS overhauled the CDC childhood vaccine schedule, reducing the number of shots recommended for all children.

You can’t blame this one on the stork. After a brief baby bump early in the COVID-19 pandemic, birth rates in the US and other wealthy countries dropped as the public health emergency eased. That ...

A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...

Experts worry Robert F. Kennedy Jr.’s Health Department will use an internal AI tool to analyze vaccine injury claims in a way that furthers his anti-vaccine agenda. The tool has not yet been deployed ...

Add Yahoo as a preferred source to see more of our stories on Google. The Trump-appointed head of the federal panel that recommends vaccines is saying that polio and measles vaccines—and perhaps every ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans to pull away from late-stage clinical trial investments in the area. “We ...